...
首页> 外文期刊>American Journal of Physiology >Role of FoxO1 in FFA-induced oxidative stress in adipocytes.
【24h】

Role of FoxO1 in FFA-induced oxidative stress in adipocytes.

机译:FoxO1在FFA诱导的脂肪细胞氧化应激中的作用。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Reactive oxygen species (ROS) production has recently been established as an essential contributor in the pathogenesis of obesity-associated insulin resistance. The FoxO1 pathway plays a role not only in nutrient sensing but also in regulating ROS production. We exposed adipocytes to free fatty acids (FFA) and demonstrated that FoxO1 protein levels decrease in a dose-dependent manner. The FoxO1 downregulation correlated with an increase in the production of ROS and a proinflammatory adipokine pattern characterized by a decrease in adiponectin and an increase in IL-6, plasminogen activator inhibitor-1, and monocyte chemotactic protein-1 mRNA expression levels. Similarly, a decrease in FoxO1 protein levels was seen in adipocytes of db/db mice compared with controls. Treatment with the sirtuin agonist resveratrol, which translocates FoxO1 to the nucleus, increased FoxO1 protein levels in adipocytes exposed to FFA. This correlated with a decrease in the generation of ROS and a partial reversal of the proinflammatory adipokine pattern. Together these results indicate that the insulin-resistant adipocyte produced by the exposure to a high concentration of fatty acids is characterized by decreased levels of FoxO1. These data also suggest that modulation of the Sirt1/FoxO1 pathway is a potentially useful therapeutic target for the obesity-induced dysfunctional adipocyte.
机译:最近,已经确定了活性氧(ROS)的产生是肥胖相关胰岛素抵抗的发病机理中的重要贡献。 FoxO1途径不仅在营养物感测中而且在调节ROS的产生中发挥作用。我们将脂肪细胞暴露于游离脂肪酸(FFA),并证明FoxO1蛋白水平以剂量依赖性方式降低。 FoxO1的下调与ROS的产生增加和促炎性脂肪因子模式有关,其特征是脂联素减少,IL-6,纤溶酶原激活物抑制剂1和单核细胞趋化蛋白1 mRNA表达水平增加。同样,与对照组相比,db / db小鼠的脂肪细胞中FoxO1蛋白水平下降。用Sirtuin激动剂白藜芦醇将FoxO1转运至细胞核,可增加暴露于FFA的脂肪细胞中FoxO1蛋白的水平。这与ROS的产生减少和促炎性脂肪因子模式的部分逆转有关。这些结果共同表明,通过暴露于高浓度的脂肪酸而产生的胰岛素抵抗性脂肪细胞的特征在于FoxO1水平的降低。这些数据还表明,Sirt1 / FoxO1途径的调节是肥胖诱导的功能性脂肪细胞功能障碍的潜在有用治疗靶点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号